Nordic ListingsIssuer Report
Nolato AB: Quarterly Trading Report 2025 Q3
Nolato AB: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=bd8976969d841afa4d20b224f78c4313b&lang=en&src=omxlink
Nolato AB: Quarterly Trading Report 2025 Q3
Earlier from Nolato
- NOLA_B: Q2 sales up 4% to SEK 2.4B, with margin and profit growth driven by Medical and Engineered Solutions
- NOLA_B: Strong margin gains and stable sales, led by Medical, with robust outlook and expansion plans
- NOLA_B: Raised financial targets and accelerated value chain expansion drive future growth
- NOLA_B: Improved profitability and validated climate targets highlight a strong 2024 performance
- NOLA_B: Q3 delivered higher sales and margins, but automotive softness and major CapEx shape the outlook
Later from Nolato
- NOLA_B: Q3 delivered higher margins and profit, with ongoing global expansion and strong financials
- Nolato's nomination committee proposes Gunilla Saltin and Martin Malmvik as new board members
- New number of shares and votes in Nolato AB (publ)
- NOLA_B: Q4 sales grew 2% adjusted for currency, with margin gains offset by material cost pressures
- Notice of Annual General Meeting 2026
Follow Nolato into a list and get an email when it puts out news.
Follow Nolato